Colchicine
- TRADE NAMES: ColBenemid; Colchiquim; Colcrys; Colgout; Goutnil; Kolkicin; Konicine
- INDICATIONS: Gouty arthritis (in adults), gout, familial Mediterranean fever
- CLASS: Alkaloid, Anti-inflammatory, Covid-19 putative drug
- HALF-LIFE: 27–31 hours (following multiple doses)
Amiodarone, Aprepitant, Atazanavir, Atorvastatin, Azithromycin, Boceprevir, Clarithromycin, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Conivaptan, Cyanocobalamin, Cyclosporine, Darunavir, Dasatinib, Delavirdine, Digoxin, Diltiazem, Efavirenz, Erythromycin, Fenofibrate, Fibrates, Fluvastatin, Gemfibrozil, Grapefruit Juice, HMG-CoA reductase inhibitors, Indinavir, Itraconazole, Ketoconazole, Lapatinib, Lopinavir, Ombitasvir/Paritaprevir/Ritonavir, P-glycoprotein inhibitors or inducers, Pravastatin, Protease inhibitors, Ritonavir, Rosuvastatin, Saxagliptin, Simvastatin, Strong CYP3A4 inhibitors, Telithromycin, Troleandomycin, Verapamil, Voriconazole
PREGNANCY CATEGORY: C
Investigated for treating COVID-19.
Contra-indicated in patients with renal or hepatic impairment where P-glycoprotein or strong CYP3A4 inhibitors are also prescribed.
Please login to see the rest of this drug profile
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
